Ofloxacin Featured News
143 items
-
12
AugYufeng Group has developed small corn into a big industry around corn deep processing
The total investment of the Ningjin Yufeng Group's Big Health Biological Industrial Park project is 5.6 billion yuan, which is more intelligent. -
11
AugDongyang City Market Supervision Bureau supports Puluo Pharmaceutical in striving to create a provincial-level commercial secret protection demonstration site
On the morning of August 10th, Lou Qiaoying, deputy director of Dongyang Market Supervision Administration, visited Puluo Pharmaceutical to convey the spirit of the Zhejiang Provincial Market Supervision Bureau on the construction of provincial trade secr -
11
AugZhejiang Haixiang Chuannan Pharmaceutical was punished by Taizhou Environmental Protection Bureau for not storing hazardous waste in accordance with environmental protection standards
Based on the situation during the on-site inspection of the parties on June 22, 2021, the Bureau initiated an investigation on June 22, 2021 for the parties’ failure to store hazardous wastes in accordance with national environmental protection standards. -
11
AugThe deep processing of corn in Heilongjiang Province reached 30 million tons, and golden corn strung the 'golden industry chain'
According to the LongTV News Network report, the golden corns are transformed into amino acids, vitamins, coenzyme Q10, etc. -
10
AugFuan Pharmaceutical's 'Ornidazole' API passed the national CDE approval
After a number of formulations passed the consistency evaluation of generic drugs, Fu'an Pharmaceutical also reported a good news on the API front. -
10
AugJiangxi Desano Pharmaceutical Co.'s APIs were successfully put into production on August 5
Since its establishment in September 2020, Jiangxi Desano Pharmaceutical Co., Ltd. has been adhering to innovative concepts, implementing objective management -
5
AugA total investment of 4.89 billion yuan Heilongjiang Huarui Biotechnology Co., Ltd. Biomedicine Phase II Project Introduction
Project name: Heilongjiang Huarui Biological Technology Co., Ltd. Biomedicine Project (Phase II) -
30
JulNational Development and Reform Commission: Promoting the green and low-carbon transformation of the API industry
The National Development and Reform Commission reported on July 30 that the Industry Development Department of the National Development and Reform Commission organized -
28
JulGreen Biological Manufacturing' Industry Calls for More Chinese 'Bacteria' Groups
At present, China is accelerating the transition from a big country in the fermentation industry to a powerful country in the fermentation industry. -
27
JulZhejiang Prologue and United Laboratories Inner Mongolia Corporation carry out strategic cooperation in the field of veterinary drugs
On July 26, Puluo Pharmaceutical issued an announcement. Recently, the company’s wholly-owned subsidiary Zhejiang Puluo Biotechnology Co., Ltd. -
27
JulProduction scale of clindamycin hydrochloride and clindamycin phosphate in Zhejiang Haixiang Pharmaceutical
Organizational Code: 91330001482332737 Production Address: No. 100 Waisha Branch Road, Jiaojiang District, Taizhou City, Zhejiang Province -
21
JulHenan Xintiandi Pharmaceutical's revenue of L-p-hydroxyphenylglycine series products
Henan Xintiandi Pharmaceutical's revenue of L-p-hydroxyphenylglycine series products -
21
JulThe scale of Shandong's pharmaceutical industry continues to grow, with an operating income of 278.3 billion yuan in 2020
Medicine is a key industry related to the national economy and people's livelihood, and an important guarantee for advancing the construction of a healthy China. -
20
JulJiangsu: Medicinal camphor raw material drug companies are punished for their monopolistic price hikes
Camphor, a common medicinal product with antiseptic and insect repellent functions in daily life, has a wide range of uses. -
19
JulHuarui Pharmaceutical advances the progress of the project and is expected to be put into operation in October
Recently, the Huarui Biomedical Project in Heilongjiang Province seized the golden period of construction -
14
JulThe deputy director of the Provincial People's Congress investigated Henan Xintiandi Pharmaceutical
On July 8, Zhao Suping, Secretary of the Party Leadership Group and Deputy Director of the Standing Committee of the Henan Provincial People's Congress -
14
JulHenan Xintiandi Pharmaceutical’s GEM IPO was accepted, and plans to raise 585 million yuan
On June 28, Henan Xintiandi Pharmaceutical Co., Ltd. (Xintiandi for short) was accepted by the Shenzhen Stock Exchange for its IPO on the Growth Enterprise Market. -
14
JulHenan Xintiandi Pharmaceutical takes the lead in formulating the industry standard of 'D-P-Hydroxyphenylglycine' to be implemented from July 1st
A few days ago, the Ministry of Industry and Information Technology issued Announcement (2021) No. 6, approving the publication of 563 industry standards -
13
JulShouguang City was awarded the 'National Starch Deep Processing Industry Cluster' and corn starch deep processing reached more than 3 million tons per year
A few days ago, the 9th Member Conference of the China Starch Industry Association and the 7th World Starch Industry Conference were held in Shanghai. Shouguang City was awarded the "National Starch Deep Processing Industry Cluster". -
8
JulFocusing on the production of pharmaceutical raw materials, Japan adjusts its overseas dependence on antibiotics and other products
Focusing on the production of pharmaceutical raw materials, Japan's domestic pharmaceutical industry has a tendency to adjust its dependence on overseas.
Breaking News
-
Styrene Weekly Report (August 31, 2026 - September 06, 2026)
Sep 7 -
Tianjin Haijing Polyamide 6 Slice Price News (2026-09-09)
Sep 9 -
Methanol Weekly Report (August 31, 2026 - September 06, 2026)
Sep 7 -
Benzene Weekly Report (August 31, 2026 - September 06, 2026)
Sep 7 -
[Styrene]: September 9, 2026 Asian Market Styrene Price Dynamics
Sep 9 -
[Urea]: International Mainstream Regional Urea Export FOB Price (20260911)
Sep 11
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)